If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Anita Orlando is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 5 Similar Profiles
Biosimilar Pharmaceuticals Medicine & Life Sciences
Adult Respiratory Distress Syndrome Medicine & Life Sciences
Inflammatory Bowel Diseases Medicine & Life Sciences
Italy Medicine & Life Sciences
Kidney Medicine & Life Sciences
Safety Medicine & Life Sciences
Lung Medicine & Life Sciences
Renal Dialysis Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2018 2019

B-lines Visualization and Lung Aeration Assessment: Mind the Ultrasound Machine Setting

Mongodi, S., Stella, A., Orlando, A. & Mojoli, F., Mar 1 2019, In : Anesthesiology. 130, 3, 1 p.

Research output: Contribution to journalArticle

Lung Ultrasound for Daily Monitoring and Management of ARDS Patients

Mongodi, S., Bonaiti, S., Stella, A., Colombo, A., Santangelo, E., Vaschetto, R., Orlando, A., Bouhemad, B. & Mojoli, F., May 1 2019, In : Clinical Pulmonary Medicine. 26, 3, p. 92-97 6 p.

Research output: Contribution to journalArticle

Adult Respiratory Distress Syndrome
Lung
Extravascular Lung Water
Pronation
Ventilator-Associated Pneumonia

Persistent pollutants: focus on perfluorinated compounds and kidney

Ferrari, F., Orlando, A., Ricci, Z. & Ronco, C., Jan 1 2019, (Accepted/In press) In : Current Opinion in Critical Care.

Research output: Contribution to journalReview article

Kidney
Renal Dialysis
Urogenital Neoplasms
Pregnancy Induced Hypertension
Glucose Intolerance

The PROSit cohort of infliximab biosimilar in IBD: A prolonged follow-up on the effectiveness and safety across Italy

Armuzzi, A., Fiorino, G., Variola, A., Manetti, N., Fries, W., Orlando, A., Maconi, G., Bossa, F., Cappello, M., Biancone, L., Cantoro, L., Costa, F., D'Incà, R., Lionetti, P., Principi, M., Castiglione, F., Annunziata, M. L., Di Sabatino, A., Di Girolamo, M., Terpin, M. M. & 43 others, Cortelezzi, C. C., Saibeni, S., Amato, A., Ardizzone, S., Guidi, L., Danese, S., Massella, A., Ventra, A., Rizzuto, G., Massari, A., Perri, F., Annese, V., Saettone, S., Tari, R., Petruzzellis, C., Meucci, G., Imperiali, G., Guglielmi, F. W., Mazzuoli, S., Caserta, L., Parodi, M. C., Colli, A., Ronchetti, A., Pugliese, D., Geccherle, A., Rogai, F., Milani, S., Renna, S., Cassinotti, A., Andriulli, A., Martino, G., Scrivo, B., Troncone, E., Kohn, A., Bertani, L., Lorenzon, G., Ghione, S., Nardone, O., Vecchi, M., Bertani, A., Bosani, M. A., Bezzio, C. & Salerno, R., 2019, In : Inflammatory Bowel Diseases. 25, 3, p. 568-579 12 p.

Research output: Contribution to journalArticle

Biosimilar Pharmaceuticals
Inflammatory Bowel Diseases
Italy
Safety
Crohn Disease

The PROSit cohort of infliximab biosimilar in IBD: A prolonged follow-up on the effectiveness and safety across Italy

Armuzzi, A., Fiorino, G., Variola, A., Manetti, N., Fries, W., Orlando, A., Maconi, G., Bossa, F., Cappello, M., Biancone, L., Cantoro, L., Costa, F., D'Incà, R., Lionetti, P., Principi, M., Castiglione, F., Annunziata, M. L., Di Sabatino, A., Di Girolamo, M., Terpin, M. M. & 43 others, Cortelezzi, C. C., Saibeni, S., Amato, A., Ardizzone, S., Guidi, L., Danese, S., Massella, A., Ventra, A., Rizzuto, G., Massari, A., Perri, F., Annese, V., Saettone, S., Tari, R., Petruzzellis, C., Meucci, G., Imperiali, G., Guglielmi, F. W., Mazzuoli, S., Caserta, L., Parodi, M. C., Colli, A., Ronchetti, A., Pugliese, D., Geccherle, A., Rogai, F., Milani, S., Renna, S., Cassinotti, A., Andriulli, A., Martino, G., Scrivo, B., Troncone, E., Kohn, A., Bertani, L., Lorenzon, G., Ghione, S., Nardone, O., Vecchi, M., Bertani, A., Bosani, M. A., Bezzio, C. & Salerno, R., 2019, In : Inflammatory Bowel Diseases. 25, 3, p. 568-579 12 p.

Research output: Contribution to journalArticle